CASE STUDY

When Migraine Digital Presence Needed Credibility, We Engaged the Right DOLs.

CASE STUDY   |   BGBx MEDICAL COMMUNICATIONS

When Migraine Digital Presence Needed Credibility, We Engaged the Right DOLs.

THE CHALLENGE

Establishing the Right Relationships to Strengthen Digital Presence in Migraine Landscape

A top 5 pharmaceutical company sought to strengthen its presence in the migraine digital landscape, where clinical conversation is increasingly shaped by neurology and headache specialists active across digital channels.

While the opportunity to engage was clear, credibility in this space depended on building relationships with the right Digital Opinion Leaders. To move forward, the company needed a structured approach to identify and engage relevant DOLs while generating insights to inform a more effective and credible online migraine presence.

THE BREAKTHROUGH

Designing an Advisory Board to Build DOL Relationships and Generate Actionable Insight

BGBx identified that the opportunity was not simply to convene an advisory board, but to structure engagement around the right neurology and headache specialist DOLs, ensuring both meaningful relationship development and practical insight generation.

The approach included:

  • A live, full-day advisory board with eight neurology and headache specialist DOLs
  • Pre- and post-meeting surveys to enhance discussion and promote continued engagement
  • Digital analysis of the therapeutic landscape to guide advisory discussions
  • Interactive workshops designed to generate clear, actionable approaches
Perspective
“You are pioneers for doing this.”
— DOL Advisor

THE RESULTS

Advisory Board-Led DOL Engagement Generated Actionable Migraine Digital Insight

Interactive workshops translated advisory discussions into clear, actionable approaches to strengthen digital engagement, while pre- and post-meeting surveys extended dialogue beyond the advisory board.

Digital landscape analysis grounded conversations in real-world data and shaped strategic direction in the migraine space.

8
DOLs Engaged

Neurology and headache specialists

Full-Day
Advisory Board

Live engagement session

Actionable
Digital Insight

Migraine strategy strengthened

Our Perspectives on Advertising

2026 Oncology Market Access TrendsBLOG

2026 Oncology Market Access Trends

1 min
Implications of the IRA’s Maximum Fair Price (MFP) NegotiationsBLOG

Implications of the IRA’s Maximum Fair Price (MFP) Negotiations

1 min
340B Drug Discount ProgramBLOG

340B Drug Discount Program

1 min

Let’s Plan Your Next Medical Communications Breakthrough

At BGBx, we design advisory boards that build meaningful relationships, generate actionable insight, and strengthen medical communications strategy.

BGBx ADVERTISING

Built to Breakthrough.

Most pharma advertising blends together. We build ours to stand out.

Strategy, science, creativity all working together, validated before launch, and sharp enough to actually change what people think, feel, and do.

ADVERTISING CAPABILITIES

We Turn Challenges into Breakthroughs.

Market leadership is shaped long before a campaign launches—by where you compete, how your brand is defined, and how consistently it shows up at the moments that influence choice.

Success requires more than standout creative. It takes alignment across strategy, brand, and execution, so every interaction reinforces value and drives action.

BGBx ADVERTISING

Built to Breakthrough.

Most pharma advertising blends together. We build ours to stand out.

Strategy, science, creativity all working together, validated before launch, and sharp enough to actually change what people think, feel, and do.

ADVERTISING CAPABILITIES

We Turn Challenges into Breakthroughs.

Market leadership is shaped long before a campaign launches—by where you compete, how your brand is defined, and how consistently it shows up at the moments that influence choice.

Success requires more than standout creative. It takes alignment across strategy, brand, and execution, so every interaction reinforces value and drives action.